Suppr超能文献

学术性医疗产品开发:技术转移组织与临床与转化科学奖联盟的新兴合作关系

Academic medical product development: an emerging alliance of technology transfer organizations and the CTSA.

作者信息

Rose Lynn M, Everts Maaike, Heller Caren, Burke Christine, Hafer Nathaniel, Steele Scott

机构信息

Benaroya Research Institute and Institute of Translational Health Sciences (ITHS) and School of Pharmacy, Department of Pharmacy, University of Washington, Seattle, Washington, USA.

出版信息

Clin Transl Sci. 2014 Dec;7(6):456-64. doi: 10.1111/cts.12175. Epub 2014 Jun 19.

Abstract

To bring the benefits of science more quickly to patient care, the NIH National Center Advancing Translational Sciences (NCATS) supports programs that enhance the development, testing, and implementation of new medical products and procedures. The NCATS clinical and translational science award (CTSA) program is central to that mission; creating an academic home for clinical and translational science and supporting those involved in the discovery and development of new health-related inventions. The technology transfer Offices (TTO) of CTSA-funded universities can be important partners in the development process; facilitating the transfer of medical research to the commercial sector for further development and ultimately, distribution to patients. The Aggregating Intellectual Property (IP) Working Group (AWG) of the CTSA public private partnerships key function committee (PPP-KFC) developed a survey to explore how CTSA-funded institutions currently interface with their respective TTOs to support medical product development. The results suggest a range of relationships across institutions; approximately half have formal collaborative programs, but only a few have well-connected programs. Models of collaborations are described and provided as examples of successful CTSA/TTO partnerships that have increased the value of health-related inventions as measured by follow-on funding and industry involvement; either as a consulting partner or licensee.

摘要

为了更快地将科学成果应用于患者护理,美国国立卫生研究院国家推进转化科学中心(NCATS)支持各类项目,以加强新医疗产品和程序的开发、测试及应用。NCATS临床与转化科学奖(CTSA)项目是这一使命的核心;它为临床与转化科学打造了一个学术家园,并支持那些参与新健康相关发明发现与开发的人员。由CTSA资助的大学的技术转移办公室(TTO)在开发过程中可以成为重要合作伙伴;促进医学研究向商业领域的转移,以便进一步开发,并最终将产品提供给患者。CTSA公私合作关键职能委员会(PPP-KFC)的知识产权整合(IP)工作组(AWG)开展了一项调查,以探究目前CTSA资助机构如何与各自的TTO对接,以支持医疗产品开发。结果显示各机构之间存在多种关系;约半数机构有正式的合作项目,但只有少数机构的项目联系紧密。文中描述了合作模式,并列举了成功的CTSA/TTO合作伙伴关系案例,这些案例通过后续资金和行业参与度(无论是作为咨询伙伴还是被许可方)来衡量,提升了健康相关发明的价值。

相似文献

5
Working with the CTSA Consortium: what we bring to the table.与 CTSA 联盟合作:我们的优势所在。
Sci Transl Med. 2010 Dec 22;2(63):63mr5. doi: 10.1126/scitranslmed.3001635.

本文引用的文献

1
Drug discovery in an academic setting: playing to the strengths.学术环境中的药物研发:发挥自身优势。
ACS Med Chem Lett. 2013 Jan 17;4(3):313-5. doi: 10.1021/ml400012g. eCollection 2013 Mar 14.
2
US academic drug discovery.美国学术性药物研发
Nat Rev Drug Discov. 2011 Jun;10(6):409-10. doi: 10.1038/nrd3462.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验